Health Care: Drugs

Acasti Pharma Inc (ACST: NASDAQ)

$0.365 n/a | n/a%
08/28/15 - 03:58 PM ET
Company Income Statement
Feb 2015 Feb 2014 Feb 2013 Feb 2012
Sales 216.39K 450.16K 707.40K 127.11K
Cost of Sales 187.98K 262.30K 396.94K 5.11K
Gross Operating Profit 28.41K 187.86K 310.45K 122.01K
Selling, General, and Administrative Expenses 4.72M 6.03M 4.19M 3.51M
Research & Development 5.21M 3.86M 2.94M 3.16M
Operating Income before D & A (EBITDA) -9.91M -9.71M -6.82M -6.55M
Depreciation & Amortization 1.87M 1.59M 649.60K 671.76K
Interest Income 69.57K 28.99K 46.14K 43.39K
Other Income - Net 8.52M -757.84K 41.82K -22.40K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -3.19M -12.03M -7.38M -7.20M
Interest Expense 3.25K 876.00 2.62K 9.01K
Pre-Tax Income -3.19M -12.03M -7.38M -7.21M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -1.32M -10.44M -6.73M -6.54M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -1.32M -10.44M -6.73M -6.54M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -1.32M -10.44M -6.73M -6.54M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.32M -10.44M -6.73M -6.54M
Preferred Dividends
Net Income Available To Common -1.32M -10.44M -6.73M -6.54M
Basic EPS from Continuing Ops. -0.01 -0.12 -0.09 -0.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.01 -0.12 -0.09 -0.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.02 -0.13 -0.09 -0.10
Basic Normalized Net Income/Share -0.01 -0.12 -0.09 -0.10
EPS fr Continuing Ops. -0.01 -0.12 -0.09 -0.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.01 -0.12 -0.09 -0.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.02 -0.13 -0.09 -0.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.01 -0.12 -0.09 -0.10
Dividends Paid per Share 0.00 0.00 0.00 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter